Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: review of actual guidelines and economic aspects of therapy
Michael Wilke,1 Rolf Grube1 1Dr. Wilke GmbH, Munich, Germany Objective: Nosocomial or more exactly, hospital-acquired (HAP) and ventilator-associated pneumonia (VAP) are frequent conditions when treating intensive care unit (ICU) patients that are only exceeded by central line-associated bloodstrea...
Main Authors: | Wilke M, Grube R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-12-01
|
Series: | Infection and Drug Resistance |
Online Access: | http://www.dovepress.com/update-on-management-options-in-the-treatment-of-nosocomial-and-ventil-a15327 |
Similar Items
-
Guideline-adherent initial intravenous antibiotic therapy for hospital-acquired/ventilator-associated pneumonia is clinically superior, saves lives and is cheaper than non guideline adherent therapy
by: Wilke MH, et al.
Published: (2011-07-01) -
Update of the treatment of nosocomial pneumonia in the ICU
by: Rafael Zaragoza, et al.
Published: (2020-06-01) -
Treatment Guidelines for Nosocomial Pneumonia: Agreeing to Disagree
by: R Bruce Light
Published: (1993-01-01) -
Response to “Treatment Guidelines for Nosocomial Pneumonia: Agreeing to Disagree”
by: Lionel A Mandell, et al.
Published: (1994-01-01) -
Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and Management
by: Elena Xu, et al.
Published: (2021-03-01)